We do not publish a verdict for Medline Inc (MDLN) and West Pharmaceutical Services Inc (WST) is overvalued.
We publish an intrinsic value for WST but not for MDLN, so the two cannot be ranked on price.
Values as of the 22 Sept 2026 close.
We do not publish a value for this company: it has no growth history of its own to project.
Leak Score 29/100 on 5 of 12 signals
Discounting its cash flows at 10.4% (average of 3 methods) values the shares at $104.26; the price of $371.09 is 256% above that value, and 71% of that value comes from beyond year five.
Leak Score 61/100 on 10 of 12 signals
| Metric | MDLN | WST |
|---|---|---|
| Verdict | Not valued | Overvalued |
| Price | $34.43 | $371.09 |
| Intrinsic value | — | $104.26 |
| Margin of safety | — | -256% |
| Leak Score | 29/100 (5/12) | 61/100 (10/12) |
| Market cap | $45.3B | $26.1B |
| Revenue growth, 5 years | — | 7.4% |
| Operating margin | 6.5% | 22.0% |
| Net margin | 2.3% | 17.0% |
| Return on equity | 4.9% | 19.1% |
| Debt to equity | 1.09 | 0.11 |
| P/E | 40.4x | 47.4x |
| Forward P/E | 21.8x | 37.1x |
| P/B | 2.6x | 8.7x |
| Dividend yield | 0.1% | 0.2% |